{
  "image_filename": "table_p4_det_3_003.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/table_p4_det_3_003.png",
  "image_type": "Table",
  "page_number": 4,
  "block_id": "det_3_003",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table presenting immunogenicity data from a clinical study, showing pre- and post-vaccination hemagglutination inhibition titers and percent response for different groups (placebo, vaccine, previously vaccinated, not previously vaccinated) across multiple influenza strains (e.g., H1N1, H3N2, B), with footnotes defining response criteria and vaccination status. Below the table is text describing an adverse event and study endpoints. does not support the claim",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table presenting immunogenicity data from a clinical study, showing pre- and post-vaccination hemagglutination inhibition titers and percent response for different groups (placebo, vaccine, previously vaccinated, not previously vaccinated) across multiple influenza strains (e.g., H1N1, H3N2, B), with footnotes defining response criteria and vaccination status. Below the table is text describing an adverse event and study endpoints.",
    "evidence_found": null,
    "reasoning": "does not support the claim",
    "confidence_notes": null
  }
}